QHSLab, Inc. Files 8-K Report
Ticker: USAQ · Form: 8-K · Filed: Apr 26, 2024 · CIK: 856984
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
QHSLab filed an 8-K on 4/26/24 covering Reg FD and financials. Formerly USA Equities.
AI Summary
On April 26, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and its fiscal year ends on December 31st. Its principal business address is in West Palm Beach, Florida.
Why It Matters
This 8-K filing provides updates on QHSLab, Inc.'s regulatory disclosures and financial statements, which are crucial for investors to understand the company's current standing and compliance.
Risk Assessment
Risk Level: low — This filing is a routine 8-K for disclosures and exhibits, not indicating any immediate significant operational or financial changes.
Key Players & Entities
- QHSLab, Inc. (company) — Registrant
- USA EQUITIES CORP. (company) — Former company name
- AMERICAN BIOGENETIC SCIENCES INC (company) — Former company name
- April 26, 2024 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for QHSLab, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on April 26, 2024.
In which state is QHSLab, Inc. incorporated?
QHSLab, Inc. is incorporated in Nevada.
What is QHSLab, Inc.'s fiscal year end?
QHSLab, Inc.'s fiscal year ends on December 31st.
What were some of QHSLab, Inc.'s former company names?
QHSLab, Inc. was formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC.
Filing Stats: 593 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-04-26 08:30:40
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value USAQ N/A Item 7.01 Regu
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-24-016061.txt ( ) — 230KB
- usaq-20240426.xsd (EX-101.SCH) — 3KB
- usaq-20240426_lab.xml (EX-101.LAB) — 33KB
- usaq-20240426_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: April 26, 2024 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman